Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Nimodipine

EU orphan designation number: EU/3/15/1554   
Active ingredient: Nimodipine
Indication: Treatment of aneurysmal subarachnoid haemorrhage
Sponsor: Dr Stefan Blesse
Thierschstraße 3, 80538 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/10/2015 Orphan designation EMA/OD/088/15 (2015)7025 of 9/10/2015